Benzinga | Sep 14, 2020 09:17AM EDT

Ampio Pharmaceuticals Shares Spike After Co. Highlights Featuring Of Co.'s Phase I COVID-19 Patient Trial Results On FOX News

ENGLEWOOD, Colo., Sept. 14, 2020 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE:AMPE),a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced that Michael Roshon, MD, PhD, Chief of Staff atPenrose-St. Francis HospitalinColorado Springs, Colorado, who served as Principal Investigator of the just completed Phase I trial of intravenous Ampion(tm) for treatment of COVID-19 patients, and David Bar-Or, MD, founder of Ampio Pharmaceuticals, were interviewed about those clinical results on a Colorado affiliateFOXnews segment titled, "Colorado Drug shows promise against COVID-19", which can be viewed in its entirety at:

https://kdvr.com/video/colorado-drug-shows-promise-against-covid-19/5844056/